300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Cryptocurrency
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Blockchain
Facebook
Social Network
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Nigeria
Isle of Man
Pakistan
Romania
Togo
Tajikistan
Zimbabwe
Oman
Colombia
Cameroon
India
Australia
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Angel Investors in United States (June 2026)

The most active angel investors investing in United States Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United States Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Milad Alucozai
Angel
17 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $110k–$55M
Jeff Dean
Angel
13 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$53M
Jaffray Woodriff
Angel
10 United States Seed, Series A, Angel Software, Biotechnology, Health Care $250k–$11M
Kingsley Advani
Angel
9 United States, Singapore, United Kingdom Seed, Pre-Seed, Series A FinTech, Biotechnology, Financial Services $120k–$183M
Farzad Nazem
Angel
9 United States, Canada Seed, Series A, Series B Health Care, Software, Analytics $750k–$50M
Jude Gomila
Angel
9 United States, United Kingdom, Canada Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $190k–$4.7M
bumpkins profile
Angel
8 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Robotics $325k–$57M
Sahin Boydas
Angel
8 United States, Mexico, Norway Seed, Series A, Series B Software, Financial Services, Information Technology $125k–$150M
Sam Altman
Angel
8 United States, Canada, Ghana Seed, Series A, Series B Software, Artificial Intelligence, Internet $1.2M–$100M
Paul Buchheit
Angel
8 United States, Canada, India Seed, Series A, Angel Software, E-Commerce, Health Care $100k–$13M
Jeff Hammerbacher
Angel
7 United States, Germany Seed, Series A, Angel Software, Artificial Intelligence, Biotechnology $330k–$25M
Alice Zhang
Angel
7 United States, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $120k–$30M
Zach Weinberg
Angel
6 United States, Israel, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, SaaS $1.4M–$30M
Wei Guo
Angel
6 United States, China, Canada Seed, Series A, Angel Software, Artificial Intelligence, Health Care $200k–$19M
Mark Cuban
Angel
5 United States, United Kingdom, Canada Seed, Series A Software, Artificial Intelligence, Blockchain $600k–$23M
Chris Gibson
Angel
5 United States, France, Switzerland Series A, Seed Biotechnology, Health Care, Life Science $4.9M–$55M
John Ballantyne
Angel
5 United States Seed, Series A, Angel Biotechnology, Health Care, Life Science $12M–$30M
Balaji Srinivasan
Angel
5 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $665k–$31M
Daniel Curran
Angel
5 United States, Canada, Brazil Seed, Series A, Series B E-Commerce, Software, Internet $600k–$50M
Jim Mellon
Angel
5 United States, United Kingdom, Israel Series A, Seed Biotechnology, Food and Beverage, Health Care $536k–$46M
Anne Wojcicki
Angel
5 United States, United Kingdom, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$70M
Fred Ehrsam
Angel
5 United States, Canada, Israel Seed, Series A, Series C Blockchain, Cryptocurrency, Software $1M–$300M
Erik Peterson
Angel
5 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, Biotechnology, SaaS $69k–$20M
Brian Armstrong
Angel
5 United States, Brazil, Libya Seed, Series A, Series B Biotechnology, Payments, Financial Services $2M–$130M
Evan Cheng
Angel
5 United States, United Kingdom, Australia Seed, Pre-Seed, Series A Software, Artificial Intelligence, Biotechnology $120k–$18M
Elad Gil
Angel
5 United States, United Kingdom, Israel Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$100M
Kevin Moore
Angel
5 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $120k–$5.2M
Daren Cotter
Angel
4 United States Seed, Series A Software, Health Care, E-Commerce $1M–$19M
Esther Dyson
Angel
4 United States, Canada, Russian Federation Seed, Series A Health Care, Software, Medical $270k–$16M
John D'Orazio
Angel
4 United States Seed, Equity Crowdfunding Medical, Health Care, Biotechnology $245k–$1.3M
Nat Turner
Angel
4 United States, China, Colombia Seed, Series A, Series B Health Care, Software, Medical $1.5M–$36M
Bradley Horowitz
Angel
4 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $150k–$120M
Brenton Saunders
Angel
4 United States Seed, Series A, Series B Health Care, Medical, Biotechnology $3.5M–$60M
Bill Gates
Angel
4 United States, Brazil, Canada Series A, Series B, Series C Energy, Biotechnology, Manufacturing $13M–$161M
Timothy A. Springer
Angel
4 United States, Canada Series A, Series B, Seed Biotechnology, Medical, Health Care $15M–$121M
Alec Nielsen
Angel
4 United States, Germany Seed, Pre-Seed Biotechnology, Biopharma, Medical $3M–$16M
Cory Levy
Angel
4 United States, Canada, United Kingdom Pre-Seed, Seed, Series A Artificial Intelligence, Software, Advertising $200k–$72M
Max Levchin
Angel
4 United States, United Kingdom, India Series A, Seed, Series B FinTech, Financial Services, Mobile $1.3M–$50M
Darian Shirazi
Angel
4 United States, Germany, Canada Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$100M
Avichal Garg
Angel
4 United States, Canada, Mexico Seed, Series A Software, Blockchain, Internet
Jack Abraham
Angel
4 United States, France, Hong Kong Seed, Series A, Series B Health Care, Software, Biotechnology $1.2M–$100M
Peter Thiel
Angel
4 United States, Germany, Canada Series A, Seed, Series B Software, FinTech, Financial Services $900k–$105M
Todd Corenson
Angel
4 United States Seed, Pre-Seed, Convertible Note Biotechnology, FinTech, SaaS $1M–$4.4M
David R. Walt
Angel
4 United States Seed, Series A, Series B Biotechnology, Genetics, Life Science $2M–$37M
Ling Wong
Angel
4 United States, Colombia Series A, Series B, Series C Biotechnology, Health Care, Medical $8.1M–$450M
Eric Kwan
Angel
4 United States, India, Canada Seed, Pre-Seed FinTech, Software, E-Commerce $125k–$9.5M
David Beyer
Angel
4 United States Seed, Series A, Angel Software, Artificial Intelligence, Machine Learning $500k–$23M
Brad Flora
Angel
4 United States, United Kingdom, Mexico Pre-Seed, Seed, Series A Software, Artificial Intelligence, SaaS $500k–$30M
Jason Calacanis
Angel
3 United States, Australia, Canada Pre-Seed, Seed, Series A Software, Internet, Artificial Intelligence $100k–$14M
Erik Moore
Angel
3 United States, Latvia Seed, Series A Mobile, Software, E-Commerce
Access all 1035 angel investors in United States Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Milad Alucozai
Angel · San Francisco, California, United States · 17 investments in United States Biotechnology startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 54
  • Round size: Seed $150k–$6.7M; Pre-Seed $110k–$1.5M; Series A $13M–$55M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 13 investments in United States Biotechnology startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 93
  • Round size: Seed $2.5M–$35M; Pre-Seed $450k–$3M; Series A $6.1M–$53M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
  • Moonlake AI — Vibe code games and worlds into existence.
  • Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
Show all investments...

Jaffray Woodriff
Angel · Charlottesville, Virginia, United States · 10 investments in United States Biotechnology startups

Angel Investor located in Charlottesville, VA

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 47
  • Round size: Seed $640k–$4.3M; Angel $250k–$2.6M; Series A $3.4M–$11M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
  • Knit — Knit helps researchers run agency-quality quant + qual research at DIY costs, by taking the most time-intensive research tasks off their plate through Researcher-Driven AI.
  • Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
Show all investments...

Kingsley Advani
Angel · San Francisco, California, United States · 9 investments in United States Biotechnology startups

Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.

Show more...

Investment focus

  • Industry: FinTech, Biotechnology, Financial Services
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 45
  • Round size: Seed $120k–$4.3M; Pre-Seed $120k–$4.5M; Series A $4M–$183M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Orbit Fab — Orbit Fab is creating the future of on-orbit satellite refueling. We maximize your operational assets by enabling mission flexibility and freedom of action in space.
  • Juvenescence — We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
  • Volumetric — Advanced materials and 3D biofabrication.
Show all investments...

Farzad Nazem
Angel · Palo Alto, California, United States · 9 investments in United States Biotechnology startups

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Show more...

Investment focus

  • Industry: Health Care, Software, Analytics
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 64
  • Round size: Seed $750k–$6.5M; Series A $2.8M–$14M; Series B $6M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
  • Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
  • TigerGraph — TigerGraph is the leading AI-powered graph database. Uncover hidden relationships, run real-time analytics at scale, and power fraud detection, customer 360, and AI
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 9 investments in United States Biotechnology startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 55
  • Round size: Seed $1.4M–$4.7M; Angel $190k–$1.3M; Pre-Seed $1M–$2.8M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
  • Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Show all investments...

bumpkins profile
Angel · 8 investments in United States Biotechnology startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Robotics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.3M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$57M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • MightyFly — MightyFly is enabling worldwide access to goods with fast, on-demand delivery services for businesses and consumers. We’re putting the infrastructure in place to connect remote locations together with long range, heavy cargo aircraft. Many areas in the world today suffer from an inability to obtain critical and often urgently needed goods andsupplies at an affordable cost. Our goal at MightyFly is to solve this problem through express, customized aerial drone delivery services. MightyFly drones will transport cargo to multiple locations in a single flight across hundreds of miles of remote terrain that is difficult if not impossible to cross with trucks or other ground vehicles. We are developing vertical-takeoff-and-landing (VTOL) drones that fly more than 300 miles, and carry payloads in excess of 50 pounds at a fraction of the cost of helicopters. Featuring automated cargo loading and unloading, and requiring no launch or recovery infrastructure, MightyFly drones will accommodate ad-hoc deliveries to undeveloped sites as well as servicing locations along established routes.
  • Bear Flag Robotics — Safe, productive and efficient farming operations for the next generation of growers. Customize, Orchestrate, Automate,and Scale your fleet to your needs.
Show all investments...

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 8 investments in United States Biotechnology startups

Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.

Show more...

Investment focus

  • Industry: Software, Financial Services, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Mexico, Norway

Investor stats

  • Total investments: 180
  • Round size: Seed $125k–$34M; Series A $6M–$35M; Series B $23M–$150M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Seezo — Seezo provides security design reviews for every feature a company builds, leveraging Gen AI to scale threat modeling. The platform helps developers ship features faster by identifying potential risks and vulnerabilities. Seezo focuses on application security (AppSec) and aims to integrate security seamlessly into the development process.
  • Neurable — Neurable develops software to understand human intent by using advanced machine learning techniques to classify the electrical signals produced by your brain. Neurable's software turns these biometric signals into actionable insights for measuring emotion and providing control of connected devices.
  • Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
Show all investments...

Sam Altman
Angel · San Francisco, California, United States · 8 investments in United States Biotechnology startups

Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Ghana

Investor stats

  • Total investments: 178
  • Round size: Seed $1.2M–$10M; Series A $6M–$70M; Series B $17M–$100M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • GALY — GALY biocrafts premium cocoa and cotton with quality, traceability, and scalable supply for modern brands.
  • BRINC Drones — BRINC is a US company developing tech in the service of public safety. Known for Drone as First Responder, indoor tactical drones and more.
  • NOYACK — NOYACK builds agentic AI technology for wealth management, starting with NOYACK.ai—the first AI agent for financial literacy - and Prophit.ai , the first opensource AI agent for portfolio optimizations of ALL asset classes. The fintech platform uses autonomous AI to deliver personalized financial guidance and construct tax-optimized portfolioscombining traditional accounts (IRAs, 401(k)s, HSAs) with private market investments in venture capital, fine art, and real estate for Millennials and Gen Z investors
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 8 investments in United States Biotechnology startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 152
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$13M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Jeff Hammerbacher
Angel · 7 investments in United States Biotechnology startups

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: United States, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Modal Labs — Modal develops machine learning software to help run code in the cloud. The software enables users to run or deploy machine learning models, massively parallel compute jobs, task queues, web apps, and more. It also writes the code to launch hundreds of custom containers and runs scripts in the cloud faster than on the local machine.
  • OpenHands — Meet OpenHands, the open-source, model-agnostic platform for cloud coding agents. Automate real engineering work securely and transparently. Build faster with full control.
  • Together AI — Together will enable researchers, developers & companies to leverage and improve artificial intelligence with an intuitive data, models & computation platform.
Show all investments...

Alice Zhang
Angel · San Francisco, California, United States · 7 investments in United States Biotechnology startups

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $120k–$5.9M; Series A $12M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Show all investments...

Zach Weinberg
Angel · New York, New York, United States · 6 investments in United States Biotechnology startups

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$6.3M; Pre-Seed $1.5M–$2.3M; Series A $3M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
  • Nym — Nym Health leverages advanced AI for medical coding, revolutionizing accuracy and speed within revenue cycle management. Discover the difference.
Show all investments...

Wei Guo
Angel · San Francisco, California, United States · 6 investments in United States Biotechnology startups

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 154
  • Round size: Seed $200k–$4.3M; Angel $375k–$10M; Series A $7M–$19M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
  • Bungalow — Bungalow is a residential real estate platform that provides renters with a more convenient, flexible, and communal living solution. It utilizes existing housing supply by signing long-term leases with homeowners, and offers multi-bedroom homes in some of the most desirable neighborhoods in cities throughout the United States.Bungalow offersprivate bedrooms with handpicked housemates in beautifully furnished homes across seven major cities. Each home comes furnished and includes wifi, utilities, housekeeping, and monthly community events for members.Andrew Collins and Justin McCarty founded Bungalow in 2016. Its headquarters is in San Francisco in California.
  • Raydiant — Raydiant empowers brick-and-mortar organizations to deliver engaging, personalized, and measurable on-screen digital experiences to delight in-store customers and engage back-of-house employees.
Show all investments...

Mark Cuban
Angel · Dallas, Texas, United States · 5 investments in United States Biotechnology startups

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Blockchain
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 186
  • Round size: Seed $600k–$9M; Series A $3.2M–$23M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • ethpass — Unlock real-world experiences by connecting your digital assets to Apple and Google Wallet
  • AlchemyNFT — AlchemyNFT is a non-fungible token (NFT) service.
  • Injective — Explore Injective: the high-performance blockchain powering decentralized finance, governance, and next-gen Web3 apps with unmatched speed and scale.
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 5 investments in United States Biotechnology startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Inato — Inato matches the right sites to the right clinical research study, globally.
  • Known Medicine — Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Show all investments...

John Ballantyne
Angel · Fargo, North Dakota, United States · 5 investments in United States Biotechnology startups

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 11
  • Round size: Series A $12M–$30M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • SmartWorx — SmartWorx is an AI-native, no-code enterprise platform that redefines how organizations build, integrate, and scale business applications. Powered by a metadata-driven architecture, SmartWorx leverages multi-agent AI to dynamically build applications, configure the platform itself, or be applied directly to an organization’s own data. The result isa unified environment that replaces fragmented ERP, CRM, and ITSM systems with extensible, real-time solutions supported by a marketplace of pre-built apps and integrations. Designed for both commercial and government use, SmartWorx enables rapid innovation, interoperability, and compliance at scale—empowering enterprises to transform how software is created and adapted.
  • GlucoTrack
Show all investments...

Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 5 investments in United States Biotechnology startups

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 242
  • Round size: Seed $2.3M–$15M; Pre-Seed $665k–$4.2M; Series A $6M–$31M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Trepa
  • Parallax — Parallax offers a cross-border payments platform for freelancers, remote workers, and businesses. The service enables receiving international client payments, holding funds in USD, exchanging currencies, and sending money to domestic bank accounts and mobile wallets. Users manage balances and transfers through a web app with quoted rates anditemized fees. The platform supports global payouts and recurring disbursements to partners and team members. Compliance measures include identity verification and transaction monitoring aligned with regulatory standards. Documentation and support resources guide account setup, funding, and cash-out.
  • Blueprint Bryan Johnson — On the surface, Blueprint may seem something about health, wellness and aging. It's really a system to make tomorrow better for you, me, the planet and our shared future with AI.
Show all investments...

Daniel Curran
Angel · San Francisco, California, United States · 5 investments in United States Biotechnology startups

Daniel Curran is the Founder and CEO at CustEx.com.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Brazil

Investor stats

  • Total investments: 145
  • Round size: Seed $600k–$5M; Series A $3.6M–$23M; Series B $2.3M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
  • Shred Video — Shred Video, a new startup launching out of Y Combinator, allows users to take footage from their iPhone, GoPro or drone and simply match it with a song from the user’s iTunes library. That’s all. Shred Video does the rest of the work.Taking into account the acceleration of the camera itself, Shred Video can pin-point the moments of action forsurfers, snowboarders, skaters and other acceleration-based sports to highlight all of the coolest clips in your footage. And beyond that, Shred Video matches those epic moments with the beat-drop of the song.
  • GC Plus — Find Your Next Home Service Expert With Ease
Show all investments...

Jim Mellon
Angel · 5 investments in United States Biotechnology startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Health Care
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 32
  • Round size: Seed $536k–$20M; Series A $4.6M–$46M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • OncoSenX — OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease.
  • Netwealth — Netwealth provides expert investment management and tailored wealth planning solutions, helping you confidently achieve your financial goals.
  • Repair Biotechnologies — Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling humanbeings to improve their health span through targeting the causes of age-related diseases and ageing itself.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Anne Wojcicki
Angel · San Francisco, California, United States · 5 investments in United States Biotechnology startups

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 60
  • Round size: Seed $1M–$12M; Series A $7M–$70M; Series B $17M–$60M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
  • The Invention Network — ScaleIP is an IP business intelligence platform that helps companies monetize IP.
  • Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
Show all investments...

Fred Ehrsam
Angel · San Francisco, California, United States · 5 investments in United States Biotechnology startups

Fred Ehrsam is the Co-Founder of Paradigm.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Series A, Series C
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 54
  • Round size: Seed $1M–$12M; Series A $7M–$45M; Series C $65M–$300M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
  • Wispr Flow — Wispr AI is a developer of the next-generation of neural interfaces to provide seamless interface with immersive technology. The company is working with the leading neuroscientist, hardware engineers, machine learning researchers, and product engineers to bring frontier technology to the mass consumer market.
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 5 investments in United States Biotechnology startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 60
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Show all investments...

Brian Armstrong
Angel · San Francisco, California, United States · 5 investments in United States Biotechnology startups

Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.

Show more...

Investment focus

  • Industry: Biotechnology, Payments, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Brazil, Libya

Investor stats

  • Total investments: 18
  • Round size: Seed $2M–$12M; Series A $13M–$30M; Series B $45M–$130M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Brain Co. — AI platform and applications for the world's most important institutions
  • NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
  • Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
Show all investments...

Evan Cheng
Angel · Burlingame, California, United States · 5 investments in United States Biotechnology startups

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Australia

Investor stats

  • Total investments: 27
  • Round size: Seed $120k–$5.8M; Pre-Seed $150k–$10M; Series A $3M–$18M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Jarsy — Jarsy Inc offers a platform for global investment opportunities using stablecoins.
  • Kontigo — We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app.
  • Kite AI — Kite AI is a purpose-built, EVM-compatible L1 designed to power the AI economy.
Show all investments...

Elad Gil
Angel · San Francisco, California, United States · 5 investments in United States Biotechnology startups

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 239
  • Round size: Seed $2M–$15M; Series A $9.5M–$50M; Series B $28M–$100M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Petual — Petual is building the AI-powered platform for audit and compliance, transforming how enterprises manage SOX, operational, financial, and compliance risk. Our intelligent agents deliver precision, coverage, and speed impossible with manual testing.
  • Harvey — Harvey is an artificial intelligence technology service provider.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
Show all investments...

Kevin Moore
Angel · Dallas, Texas, United States · 5 investments in United States Biotechnology startups

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 99
  • Round size: Seed $190k–$5.2M; Pre-Seed $120k–$3.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VantedgeAI — Fine-tuned AI models for scaling credit investing workflows, reducing analysis time and costs by up to 10x, and setting a new standard in rapid, cost-effective deal analysis and monitoring with initial focus on MBS, ABS, CLOs, etc.
  • Binarly — Binarly is the world's most advanced automated firmware supply chain security platform. Using cutting-edge machine-learning techniques, Binary identifies both known and unknown vulnerabilities, misconfigurations, and malicious code in firmware and hardware components.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Show all investments...

Daren Cotter
Angel · Minneapolis, Minnesota, United States · 4 investments in United States Biotechnology startups

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 82
  • Round size: Seed $1M–$5M; Series A $3.2M–$19M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Onsetto — Onsetto helps banks capture primary operating accounts by seamlessly switching payroll, AR/AP, and cash flows during customer onboarding.
  • Continuum — Simplify B2B returns, warranties, and repairs with Continuum; the only Returns Management Software designed for distributors and manufacturers.
  • Evecxia Therapeutics — Evecxia Therapeutics is dedicated to realizing the therapeutic potential of 5-hydroxytryptophan (5-HTP) for the treatment of mental illness.
Show all investments...

Esther Dyson
Angel · New York, New York, United States · 4 investments in United States Biotechnology startups

Esther Dyson - Founder @ Way to Wellville

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A
  • Geography: United States, Canada, Russian Federation

Investor stats

  • Total investments: 72
  • Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Show all investments...

John D'Orazio
Angel · New York, New York, United States · 4 investments in United States Biotechnology startups

John D'Orazio is the Founder and Managing Partner of Proton Enterprises. He previously worked at SlideMoor as an Executive Partner. John D'Orazio attended Xavier University.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Equity Crowdfunding
  • Geography: United States

Investor stats

  • Total investments: 17
  • Round size: Seed $245k–$1.3M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Twined — Have you ever spent hours trying to find that perfect product? Ever sifted through online reviews feeling like many of them were fake or written by people who weren't anything like you? These are the things that keep us up at night!Twined helps you easily discover unbiased product reviews and recommendations from real people that you canactually trust. We handpick our Tastemakers from around the web based on their knowledge and integrity.
  • Vascular Genesis — A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products -- with self-healing capabilities that lower the risk of rejection, infection, and stenosis. Funding prior to formation: $2.5 million.
  • Atreon Orthopedics — A medical device company building a line of orthopedic products that provide a structure for tissue growth and healing of sports medicine injuries including tendon ruptures/tears.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nat Turner
Angel · New York, New York, United States · 4 investments in United States Biotechnology startups

Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, China, Colombia

Investor stats

  • Total investments: 75
  • Round size: Seed $1.5M–$5.5M; Series A $3M–$23M; Series B $5M–$36M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
  • Memora Health — Meet patients where they are. Digitize your clinical workflows to modernize and simplify patient care.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 4 investments in United States Biotechnology startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 114
  • Round size: Seed $150k–$18M; Series A $5.8M–$36M; Series B $19M–$120M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies
  • Odyssey — Odyssey operates as an AI start-up, provides hollywood-grade visual AI.
Show all investments...

Brenton Saunders
Angel · Parsippany, New Jersey, United States · 4 investments in United States Biotechnology startups

Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 9
  • Round size: Seed $3.5M–$14M; Series A $20M–$23M; Series B $40M–$60M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Wondermind — Welcome to Wondermind, your home for approachable, expert-backed mental health content you can actually use.
  • Nucleus — Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
  • Lipidio Pharmaceuticals — A Unique Approach to Treating Obesity Precision Targeting of the Skin Exploiting the skin as an endocrine organ Historically regarded as a protective barrier organ, the skin is now recognized as an active endocrine organ capable of synthesizing, and secreting diverse hormones and signaling
Show all investments...

Bill Gates
Angel · Seattle, Washington, United States · 4 investments in United States Biotechnology startups

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Series C
  • Geography: United States, Brazil, Canada

Investor stats

  • Total investments: 95
  • Round size: Series A $13M–$105M; Series B $14M–$161M; Series C $14M–$135M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Echodyne — Echodyne develops and manufactures meta-materials-based radar technologies. The company combines the patented technology of metamaterials with powerful software to create a radar sensor with unprecedented performance at commercial price points. Echodyne's patented technology and powerful software create a high-performance radar platform thatproduces security and machine autonomy solutions for government, defense, and industry.Echodyne was founded in 2014 and is headquartered in Kirkland, Washington.
  • TerraPower — Leading innovations in nuclear applications for reactor and storage technology, while advancing methods to transform the fight against cancer.
  • Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
Show all investments...

Timothy A. Springer
Angel · Cambridge, Massachusetts, United States · 4 investments in United States Biotechnology startups

Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada

Investor stats

  • Total investments: 10
  • Round size: Series A $52M–$101M; Series B $15M–$121M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Prenuvo — Changing the medical paradigm from sick care to proactive healthcare
  • Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
  • Morphic Therapeutic — Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.
Show all investments...

Alec Nielsen
Angel · Cambridge, Massachusetts, United States · 4 investments in United States Biotechnology startups

Alec Nielsen is the Founder & CEO at Asimov.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Germany

Investor stats

  • Total investments: 6
  • Round size: Seed $3M–$16M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
  • Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
  • General Proximity — General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
Show all investments...

Cory Levy
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups

Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Advertising
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 71
  • Round size: Seed $1.6M–$15M; Pre-Seed $200k–$3.3M; Series A $14M–$72M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Wander — Never book a bad vacation home again. Every Wander comes with hotel-grade amenities, inspiring views, pristine cleaning and 24/7 concierge service.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
  • Swish Robotics — Embodied Intelligence for the Home
Show all investments...

Max Levchin
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups

Max Levchin is the Founder and CEO of Affirm. He previously worked at the Consumer Financial Protection Bureau as an Advisory Board Member. Max Levchin attended the University of Illinois Urbana-Champaign.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Mobile
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 110
  • Round size: Seed $1.3M–$10M; Series A $4M–$27M; Series B $7.5M–$50M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Bland AI — Transform your enterprise communication with Bland AI. Automate inbound and outbound phone calls using AI that sounds human. Perfect for sales, customer support, and operations with customizable voices and seamless integrations.
  • CoPilot — CoPilot is pioneering Assisted Commerce for big-ticket purchases – starting with cars. You are the one spending the money - shouldn't you have an expert on your side? We founded CoPilot to make that a reality. For the average car buyer, who is not a car expert or enthusiast, car shopping can be a time consuming, frustrating process that leavespeople feeling alone and disadvantaged. CoPilot is changing this dynamic. Like a trusted friend who is knowledgeable about cars, knows where to look and what to buy, CoPilot provides car shoppers with an expert partner who empowers them to discover the perfect car at the best possible price with ease and confidence.
  • Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.
Show all investments...

Darian Shirazi
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups, 8 in the past 12 months

Darian Shirazi is the Managing Partner of Gradient.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 172
  • Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$100M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • SolveAI
  • Rowspace — Rowspace provides an AI platform for financial institutions to make decisions using proprietary data. The platform focuses on organizing, processing, and analyzing internal datasets alongside market information. It applies artificial intelligence and machine learning techniques tailored to financial workflows. Rowspace supports use cases such asinvestment research, risk analysis, and product strategy. The company works with financial services firms that want to operationalize data for day-to-day and strategic decisions.
  • Harmattan AI — Building the Future of Autonomous Warfare.
Show all investments...

Avichal Garg
Angel · Stanford, California, United States · 4 investments in United States Biotechnology startups

Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.

Show more...

Investment focus

  • Industry: Software, Blockchain, Internet
  • Stage:Seed, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 85
  • Lead/follow: no public data

Portfolio highlights

  • Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Matic — The world's most advanced floor cleaner. Your home's best helper.
  • Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Jack Abraham
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups

Jack Abraham is based out of Florida and is the Chairman and Co-Founder of Indomo. Jack previously worked at TalkIQ as a Co-Founder and Investor. Jack Abraham attended The Wharton School.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, France, Hong Kong

Investor stats

  • Total investments: 37
  • Round size: Seed $1.2M–$20M; Series A $5M–$50M; Series B $17M–$100M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Iron Fish — Enable the free flow of assets through accessible and private cryptocurrency.
  • Wally Health — Unlimited dental cleanings and whitening for $199/year
  • NUE Life Health — NUE Life aims to improve mental wellness by enhancing brain function, performance, and longevity through evidence based and scientifically proven mental health treatments and products.
Show all investments...

Peter Thiel
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 215
  • Round size: Seed $900k–$8.5M; Series A $3M–$32M; Series B $16M–$105M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Hebbia — Hebbia's neural search lets you execute research 10X faster and 10X more accurately. Transform your productivity today.
  • Mercor — Find top-tier, remote, AI roles for your expertise. Available only on Mercor.
  • Reserve — Reserve is a universal currency company. Reserve provides people with hyperinflation protected savings accounts to protect and use their money globally. They offer rtokens, collateral baskets, and over collateralization.
Show all investments...

Todd Corenson
Angel · Los Gatos, California, United States · 4 investments in United States Biotechnology startups

Todd Corenson - Founder @ Enlon

Show more...

Investment focus

  • Industry: Biotechnology, FinTech, SaaS
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States

Investor stats

  • Total investments: 9
  • Round size: Seed $1M–$4.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
  • HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
  • iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.
Show all investments...

David R. Walt
Angel · Boston, Massachusetts, United States · 4 investments in United States Biotechnology startups

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Show more...

Investment focus

  • Industry: Biotechnology, Genetics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 8
  • Round size: Seed $2M–$5M; Series A $18M–$25M; Series B $5.4M–$37M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Vizgen — Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The highthroughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms.
  • Stoicheia — NAGASPIN99 adalah link situs slot gacor hari ini yang menawarkan bonus berlimpah khusus pemain baru. Klik Daftar dan raih kemenangan besar bersama naga api sekarang juga.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Ling Wong
Angel · Seattle, Washington, United States · 4 investments in United States Biotechnology startups

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Colombia

Investor stats

  • Total investments: 29
  • Round size: Series A $8.1M–$83M; Series B $32M–$300M; Series C $90M–$450M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • BioAge Labs — BIOAGE is a VC-backed biotech company aimed at finding drugs that extend healthspan using machine learning and biomarkers to speed up the discovery process.
  • Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
  • Collective Health — Collective Health gives companies a smarter alternative to traditional health insurance. Through a cloud-based, integrated health benefits platform, the company enables self-insured employers to get more out of their healthcare investment while taking better care of their people. Collective Health has seen exponential traction in the $1.2trillion employer-sponsored insurance market -- its membership has grown by 500x in just three sales cycles. Currently, the company covers 70,000 employees and dependent lives across 15 employers; clients include Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
Show all investments...

Eric Kwan
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

Show more...

Investment focus

  • Industry: FinTech, Software, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 55
  • Round size: Seed $1M–$9.5M; Pre-Seed $125k–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Treinta — Treinta is a digital ledger app for Latin American microbusinesses. Through Treinta, users can easily record transactions by assigning products from their inventory and see how their business metrics evolve in real time. The app helps owners save up to 30 minutes a day in bookkeeping related tasks and improve efficiency by over 30%. Out of the 50million microbusinesses in LATAM, today 90% still track their sales and expenses by using pen and paper.
  • Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
  • Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot
Show all investments...

David Beyer
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups

David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 36
  • Round size: Seed $1.2M–$4M; Angel $500k–$2.2M; Series A $2.7M–$23M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Airtable — 500,000+ brands use Airtable to enable real-time collaboration, automate repetitive tasks & manual work, and streamline business processes in minutes. Join them.
  • Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
  • Skycatch — Industry-Leading Drone Automation and AI-Driven Data Analysis Platform Transforming Global Industries
Show all investments...

Brad Flora
Angel · San Francisco, California, United States · 4 investments in United States Biotechnology startups

Brad Flora is a Visiting Partner at Y Combinator. He is a former Co-Founder and CEO of Perfect Audience. Mr. Flora received a BA from Princeton University in English and an MS in Journalism from Northwestern.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, United Kingdom, Mexico

Investor stats

  • Total investments: 218
  • Round size: Seed $500k–$4.4M; Pre-Seed $500k–$500k; Series A $1M–$30M
  • Lead/follow: 51% lead, 49% follow

Portfolio highlights

  • SWAP — Swap empowers companies to transform their financial operation with an innovative approach, technology, and business model. SWAP’s APIs offer clients end-to-end, white-label, financial solutions. Connected to them, its clients are able to develop complete financial ecosystems including pre-paid cards, digital wallets, financial services and furthermonetize their platform while expanding their core experience. It removes barriers and generates new business lines for companies, effectively creating internal fintech.
  • Truewind — Using AI to power bookkeeping & finance means less errors, more transparency, and faster monthly close
  • Ellipsis — Automated code reviews and bug fixes. Software engineers are more productive with Ellipsis, a developer tool that catches bugs, answers questions, and generates working, tested code.
Show all investments...

Jason Calacanis
Angel · San Francisco, California, United States · 3 investments in United States Biotechnology startups

Jason Calacanis is the Founder and CEO of Inside.com and Launch. He previously worked at Weblogs as a Co-Founder and CEO. Jason Calacanis attended Fordham University.

Show more...

Investment focus

  • Industry: Software, Internet, Artificial Intelligence
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Australia, Canada

Investor stats

  • Total investments: 431
  • Round size: Seed $875k–$5M; Pre-Seed $100k–$2.1M; Series A $2.7M–$14M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Dexla — Build B2B apps quickly with an AI-powered front-end software engineer. Type in what your company does and watch Buck build your app for you.
  • Bonjuur — Housekeeping Membership that tidies up your house daily and cleans room by room, for a serene life. Welcome to Bonjuur Life.
  • Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
Show all investments...

Erik Moore
Angel · San Francisco, California, United States · 3 investments in United States Biotechnology startups

Erik Moore is the Founder and Managing Director of Base Ventures, an early-stage tech venture fund. He was one of the first investors in Zappos (sold for 1.2B to Amazon) and an early investor in Plangrid, sold to Autodesk for $875mm. Prior to Base Ventures, Erik spent 15 years in investment banking at Merrill Lynch. He recently joined the boardof the Common Ground Foundation, founded by Grammy, Oscar and Emmy award winning artist, Common, and he currently serves as a board member for P.A.C.E, a private philanthropic group. He was recognized as #10 on a list of the top 25 most influential blacks in tech by Business Insider (John Thompson, Chairman of Microsoft was ranked #1). He mentors and advises several known professional athletes. Erik earned his B.A. from Dartmouth College, an MA in French from the University of Pennsylvania, and his MBA from The Wharton School of Business.

Show more...

Investment focus

  • Industry: Mobile, Software, E-Commerce
  • Stage:Seed, Series A
  • Geography: United States, Latvia

Investor stats

  • Total investments: 79
  • Lead/follow: no public data

Portfolio highlights

  • Swapbox — Swapbox is an easy and convenient delivery system that enables people to send and receive packages using a Swapbox kiosk. The kiosks, which are completely automated, are situated in convenient locations including grocery stores, petrol stations and coffee shops, meaning that customers do not need to rush to the post office by 3pm to send theirpackages. Customers simply place their item/s in the Swapbox kiosk and input their details using the touchscreen. The recipient then collects the package from a local Swapbox using the code they received through text or email. Swapbox sets itself apart by focusing on consumer satisfaction, experience and convenience.Swapbox is currently available in San Francisco and Santa Clara.
  • Pigeonly — Pigeonly offers reliable inmate communication services, including phone calls, photos, and mail. Stay connected to your loved ones in prison easily and affordably.
  • Share Practice — Share Practice helps doctors identify and understand the most effective clinical treatments based on the success of other doctors.
Show all investments...

Biotechnology Angel investor funding in United States at a glance

Stats across 1k deals from 1k investors.

1k
investors
in United States Biotechnology startups
1k
deals
in United States Biotechnology startups
$9.7M
median round
in United States Biotechnology startups
15%
lead investors
lead at least one round
33%
Seed
most common funding stage

Access all 1035 angel investors in United States Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 1035 angel investors investing in United States Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists